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  Worry exposure (WE) is a core of cognitive-behavioral treatment for generalized anxiety 
disorder (GAD). The present study was carried out to examine the efficacy of WE in treating 
patients with GAD.  Three patients with GAD were selected using Structured Clinical Interview 
for DSM-IV (SCID) based on disorders axis I. Subjects were selected using purposeful 
sampling, and underwent the treatment after gaining treatment needs. Multiple baseline 
experimental single case study was used as the method of the present study. The treatment 
program was carried out for 8 weekly sessions, with a follow up period of 3 months later 
treatment ending. Subjects completed Pennsylvania State Worry Questionnaire (PSWQ) and 
Cognitive Avoidance Questionnaire (CAQ). Research findings represented that WE decreased 
the intensity of GAD symptoms: Pathologic worry and cognitive avoidance. WE has suitable 
efficacy in treating Generalized Anxiety Disorder and it maintains suitable efficacy in treating 
GAD.    
   © 2013 Growing Science Ltd.  All rights reserved.
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1. Introduction 
Generalized anxiety disorder (GAD) is normally defined in the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV) as “the presence of persistent, excessive anxiety and 
worry about a number of events and occurring on more days than not for >6 months”. In addition, the 
patient has to experience, at least, three of the following six symptoms including restlessness or 
feeling keyed up or on edge, being easily fatigued, difficulty concentrating or mind going blank, 
irritability, muscle tension, and sleep disturbance. There are different types of patients who may 
experience many of these symptoms; nevertheless, due to the DSM-IV requirement of excessive   1660
worries with symptoms being present for >6 months will not recognize this diagnosis despite 
experiencing substantial impairment in functioning (Bienvenu et al., 1998). 
 
Overall, one of popular psychosocial treatments for the treatment of GAD is cognitive-behavioral 
therapy (CBT). The components of this therapy may be different to include the following: education 
about the symptoms and causes of anxiety, cognitive restructuring, Worry exposure, applied 
relaxation, increasing awareness, learning to monitor of anxious symptoms presenting as physical 
symptoms, and the automatic thoughts of worry created from situational and behavioral cues. Patients 
are taught to manage these symptoms through training in arousal reduction techniques (Roemer & 
Orsillo, 2002).  
 
Worry exposure (WE) is a core of cognitive-behavioral treatment for generalized anxiety disorder 
(GAD) (Borkovec & Newman, 1999; Borkovec et al., 2004).  Past meta-analyses evaluating the 
effectiveness of CBT for GAD implemented general measures of anxiety to evaluate symptom 
severity and improvement. However, these studies do not sufficient support on whether CBT 
substantially reduces the cardinal symptom of GAD: pathological worry. Covin et al. (2008) 
performed a meta-analysis to evaluate relevant outcome studies, including the use of the Penn State 
Worry Questionnaire as the primary outcome variable. They reported a large overall effect size (ES) 
moderated by age and modality of treatment. Specifically, the largest gains were detected for younger 
adults and for individual treatment. Analyses also disclosed overall maintenance of gains at 6- and 
12-month follow-up.  
 
According to Hoyer et al. (2009), WE is a core element of cognitive-behavioral treatment for GAD. 
Hoyer et al. (2009) examined whether WE alone is as efficacious as the empirically supported stand-
alone treatment for GAD, applied relaxation (AR). They reported that a stand-alone exposure in sensu 
technique, WE, could be efficacious in the treatment of GAD. Kessler et al. (2005) investigated 
prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity 
Survey Replication.  
 
Linden et al. (2004) performed a controlled clinical trial to evaluate the efficacy of CBT treatment in 
outpatients with pure GAD who were treated by a therapist working in routine care. They concluded 
that CBT could an effective technique of treatment for GAD and differences between control and 
treatment group were comparable to or larger than those reported in studies on antidepressant drugs. 
Liss et al. (2005) performed a sensory processing sensitivity and its relationship with parental 
bonding, anxiety, and depression.  
 
Mitte (2005) performed a meta-analysis of cognitive-behavioral treatments for generalized anxiety 
disorder by performing a comparison with pharmacotherapy.  Warner et al. (2009) executed a CBT 
for anxiety and associated somatic complaints in pediatric medical settings and used an open pilot 
study as a case study. Wells and King  (2006) discussed metacognitive therapy for generalized 
anxiety disorder. Wolitzky-Taylor and Telch (2010) measured efficacy of self-administered 
treatments for pathological academic worry.  
 
Alilou et al. (2011) compared the intolerance of uncertainty, cognitive avoidance, negative problem 
orientation and positive beliefs about worry in generalized anxiety disorder patients with normal 
individuals. Ballenger et al. (2001) discussed the views of the International Consensus Group on 
Depression and Anxiety and reported that cognitive-behavioral therapy was the preferred form of 
psychotherapy for GAD, although when GAD is comorbid with depression, pharmacotherapy is 
increasingly indicated (Beck et al., 1996; Bennett-Levy et al., 2005).  
 
Davidson (2004) implemented  benzodiazepines in social anxiety disorder, GAD, and posttraumatic 
stress disorder and proposed some suggestion to reduce the effect of social anxiety disorder. Dugas G. Shahmoradi et al. / Management Science Letters 3 (2013) 
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and Robichaud (2007) presented a comprehensive review on  cognitive-behavioral treatment for 
generalized anxiety disorder and discussed the challenges are faced from science perspective to 
practice. Fisher (2007) discussed the efficacy of psychological treatment for generalized anxiety 
disorder. Hamidpour (2008) examined the efficacy and effectiveness of mindfulness - based cognitive 
therapy (Tyrer, 1999) in treatment and presentation of relapse and recurrence of dysthymia.  
 
The organization of this paper is organized as follows. We first present details of our different tests 
we implement on three patients in section 2. Section 3 presents details of our computational results 
and finally concluding remarks are given in the last to summarize the contribution of this paper.  
 
2. The proposed method  
 
The present study examines the efficacy of WE in treating patients with GAD. Three patients with 
GAD were selected using Structured Clinical Interview for DSM-IV (SCID) based on disorders axis 
I. Table 1 shows personal characteristics of the patients. 
 
Table 1 
Personal characteristics of the patients 
Group  Gender  Age  Marital status  Level of Educations  Medication 
A  Female  45  Married  Master’s degree  Drug medication 
B Female  36  Single  Diploma   No  medication 
C  Male  24  Single  Bachelor of science  Drug medication 
 
Subjects are selected using purposeful sampling, and underwent the treatment after gaining treatment 
needs. Multiple baseline experimental single case study is then used as the method of the present 
study. The treatment program is carried out for 8 weekly sessions, with a follow up period of 3 
months later treatment ending. Subjects completed Pennsylvania State Worry Questionnaire (PSWQ) 
and Cognitive Avoidance Questionnaire (CAQ).  
 
3. The results  
 
In this section, we present details of our findings on the experiments. Table 2 demonstrates the results 
of PSWQ and CAQ on three samples. 
 
Table 2 
The summary of the results of PSWQ and CAQ on three samples  
 A  B  C 
PSWQ (based-line)  70    65   63   
PSWQ (first session)  6 9    62    60   
PSWQ (fourth session)  52    47    41   
PSWQ (eighth session)  42    32    37   
% of recovery   40%   51%    41%   
Total % of recovery     44%     
CAQ (based-line)  94    80    77   
CAQ (first session)  91    79    74   
CAQ (fourth session)  63    49    55   
CAQ (eighth session)  52    43    40   
% of recovery  52%    46%    48%   
Total % of recovery     46%    
 
In order to have a better understanding on comparing the effect of different tests on three patients, we 
have depicted them and Fig. 1 demonstrates the results of PSWQ and CAQ tests.   1662
 
 
Fig. 1. The results of PSWQ and CAQ tests 
 
As we can observe from the results of Table 2 and Fig. 1, the level of PSWQ and CAQ among three 
patients have been reduced after the eighth sessions. We have measured the level of STAI-T and 
BDI-II for all three patients and the results are summarized in Fig. 2 and Table 3.  
 
Table 3 
The summary of the results of STAI-T and BDI-II on three samples  
 A  B  C 
STAI-T (based-line)  52    51    52   
STAI-T (first session)  49    50    49   
STAI-T (fourth session)  41    31    41   
STAI-T (eighth session)  28    21    28   
% of recovery   46%  59%  46%   
Total % of recovery     52%     
BDI-II (based-line)  29    34    29   
BDI-II (first session)  26    33    26   
BDI-II (fourth session)  16    21    16   
BDI-II (eighth session)  10    15    10   
% of recovery  66%  56%    66%   
Total % of recovery     61%    
 
 
 
Fig. 2. The results of STAI-T and BDI-II tests 
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Again, we can observe from the results of Table 3 and Fig. 3, the level of STAI-T and BDI-II among 
three patients have been reduced after the eighth sessions. 
 
4. Conclusion 
 
This is the second study investigating the efficacy of WE as stand-alone treatment for patients with 
DSM-IV GAD. The patients demonstrated distinct improvements on all outcome measures in active 
treatment conditions. Therefore, symptoms of anxiety and depression, excessive worrying and 
Cognitive Avoidance were reduced. These improvements appeared stabile, as marked by 3-month 
follow-up assessments. One particularly interesting finding was that all secondary outcome measures 
designed to evaluate cognitive change were efficiently reduced despite the fact that no clear cognitive 
intervention was applied. These results are consistent with other studies that question the necessity of 
clear cognitive interventions. Although the assumed pathways through which WE brought about 
change clearly differ, they may have a higher-level form in common. For instance, treatment enable 
the patient to feel more competent when confronted with upcoming worries. 
 
  This form of competency is often described as self-efficacy and may indirectly impact related 
(negative) beliefs about worrying as well the necessity to control one’s own thinking. Our analyses 
did not disclose any moderating impact of psychiatric comorbidity on the treatment outcome, as the 
improvements were maintained even after controlling for another comorbid disorders. However, this 
does not mean that comorbid disorders are neutral for the therapeutic effect. Moderate and severe 
forms of depression are seen as a contraindication for WE and patients reaching the respective degree 
of severity of depression were excluded from the present study. Consequently, our results only 
confirm the view that WE can be applied successfully when mild depression or other comorbid 
conditions such as anxiety disorders are present. Furthermore, other potential moderating such as 
treatment expectations or the quality of the therapeutic alliance where not found to influence the 
results in a significant way. 
 
In summary, in this second trial of WE as a stand-alone treatment for GAD we found this method to 
be efficacious. Although WE represent effective principles of change in GAD, this treatment should 
be further developed more systematically combined with other treatment components. 
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